8 Results for "

CIPN

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "CIPN" in MCE Product Catalog:

Cat. No.: HY-101096
CAS No.: 953778-58-0
Purity:  99.96%
Synonyms: MK-8998; CX-8998; JZP385
Target:  

Calcium Channel

Research Areas:  

Neurological Disease Cancer

Suvecaltamide (MK-8998) is a selective T-type calcium channel inhibitor with oral efficacy. Suvecaltamide exhibits no cytotoxicity in myeloma cell lines and does not affect the antitumor efficacy of Bortezomib (BTZ). Suvecaltamide reverses BTZ-induced peripheral neuropathy (CIPN) in mouse and rat models, and helps inhibit myeloma growth .
loading...
    loading...
Cat. No.: HY-B0993
CAS No.: 140678-14-4
Synonyms: MnDPDP
Target:  

Apoptosis

Research Areas:  

Neurological Disease Cancer

Mangafodipir trisodium (MnDPDP), hepatocellular-specific contrast agent, is an efficacious inhibitor of CIPN (chemotherapy-induced peripheral neuropath) and other conditions caused by cellular oxidative stress. Mangafodipir trisodium shows no negative interference with the tumoricidal activity of chemotherapy .
loading...
    loading...
Cat. No.: HY-148948
CAS No.: 2790481-63-7
Purity:  99.67%
Target:  

NAMPT

Research Areas:  

Neurological Disease

NAMPT activator-3, a NAT derivative, is a NAMPT activator with an EC50 of 2.6 μM and a KD of 132 nM. NAMPT activator-3 effectively protects cultured cells from FK866 (HY-50876)-mediated toxicity. NAMPT activator-3 exhibits strong neuroprotective efficacy in a chemotherapy-induced peripheral neuropathy (CIPN) mouse model without any overt toxicity .
loading...
    loading...
Cat. No.: HY-161918
CAS No.: 3046146-15-7
Research Areas:  

Neurological Disease

SARM1-IN-3 (Example 30) is a SARM1 inhibitor. SARM1-IN-3 can be used in the study of chemotherapy induced peripheral neuropathy (CIPN) .
loading...
    loading...
Cat. No.: HY-123239
CAS No.: 1801243-39-9
Target:  

GPR55

Research Areas:  

Neurological Disease

KLS-13019 is an orally active GPR55 receptor antagonist and a structural analogue of cannabidiol (CBD). It can prevent and reverse chemotherapy-induced peripheral neuropathy (CIPN) in a dose-dependent manner in rats .
loading...
    loading...
Cat. No.: HY-B0993A
CAS No.: 155319-91-8
Research Areas:  

Cancer

Mangafodipir, hepatocellular-specific contrast agent, is an efficacious inhibitor of CIPN (chemotherapy-induced peripheral neuropath) and other conditions caused by cellular oxidative stress. Mangafodipir shows no negative interference with the tumoricidal activity of chemotherapy .
loading...
    loading...
Cat. No.: HY-101096R
CAS No.: 953778-58-0
Synonyms: MK-8998 (Standard); CX-8998 (Standard); JZP385 (Standard)
Suvecaltamide (Standard) is the analytical standard of Suvecaltamide (HY-101096). This product is intended for research and analytical applications. Suvecaltamide (MK-8998) is a selective T-type calcium channel inhibitor with oral efficacy. Suvecaltamide exhibits no cytotoxicity in myeloma cell lines and does not affect the antitumor efficacy of Bortezomib (BTZ). Suvecaltamide reverses BTZ-induced peripheral neuropathy (CIPN) in mouse and rat models, and helps inhibit myeloma growth .
loading...
    loading...
Cat. No.: HY-179523
CAS No.: 2635394-10-2
Carba1 is a bifunctional Carbazole (HY-D0204) derivative that activates nicotinamide phosphoribosyltransferase (NAMPT) and enhances NAD biosynthesis. Carba1 binds to colchicine site of tubulin, enhancing the anti-tumor effect of various chemotherapy drugs, such as Paclitaxel (HY-B0015). Carba1 exerts neuroprotective effect and can regulate cell energy metabolism. Carba1 can be used for the researches of cancer and chemotherapy-induced peripheral neuropathy (CIPN) .
loading...
    loading...